BEIJING, Nov. 17 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced shareholder resolution adopted at its annual general meeting of shareholders held in Beijing on November 16, 2009.
At the annual general meeting, the Company's shareholders approved the China Medical Technologies, Inc. 2009 Equity Incentive Plan (the "2009 Plan") as adopted by the Company's board of directors and proposed for shareholders' approval by the Company. The terms of the 2009 Plan can be found in the Company's Form 6-K furnished to the U.S. Securities and Exchange Commission (the "SEC") on November 17, 2009, which can be accessed on the Company's Investor Relations website at http://ir.chinameditech.com and on the SEC's website at http://www.sec.gov . The Company's shareholders did not adopt any other resolution at the annual general meeting.
About China Medical Technologies, Inc.
China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic (IVD) products using Enhanced Chemiluminescence (ECLIA) technology, Fluorescent in situ Hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology to detect and monitor various diseases and disorders. For more information, please visit http://www.chinameditech.com .
For more information, please contact:
Winnie Yam
Tel: +852-2511-9808
Email: IR@chinameditech.com
